European industry gets ball rolling again on EU/US MRA (Mutual Recognition Agreement)
This article was originally published in Clinica
Efforts are underway to revive the long-foundering device annex of the US-EU Mutual Recognition Agreement (MRA). The 1997 accord was once seen as a way of reducing the regulatory burdens that hamper transatlantic trade without the need for full regulatory harmonisation.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.